Development of a World Health Organization indicator and corresponding questions to measure effective coverage of rehabilitation. [PDF]
De Groote W +20 more
europepmc +1 more source
ABSTRACT Objective Considerable efforts have been dedicated to developing effective treatments for post‐stroke executive impairment (PSEI), among which repetitive transcranial magnetic stimulation (rTMS) has shown great potential. This study aimed to investigate the therapeutic effects of high‐frequency rTMS on working memory (WM) and response ...
Mengting Lao +6 more
wiley +1 more source
Adapting the World Health Organization 5 Well-Being Index for Emergency Activation and Response Planning in a US Health Care Setting. [PDF]
Breeher LE +7 more
europepmc +1 more source
Tuberculosis control in the Western Pacific region [PDF]
World Health Organization(Western Pacific Region)
core
[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich +19 more
wiley +1 more source
Correction to: The World Health Organization ageism towards older persons scale: preliminary validation of a novel measure of ageist stereotypes, prejudices, and discrimination in four different countries. [PDF]
europepmc +1 more source
Implications of U.S. withdrawal from the World Health Organization on health financing in Africa. [PDF]
Sokunbi TO, Umar AB, Eyo UB.
europepmc +1 more source
Objective We evaluated the ability of the Renal Activity Index for Lupus (RAIL) to discriminate active lupus nephritis (LN) in adult patients with active systemic lupus erythematosus (SLE) and differentiate LN treatment response. Methods Urine samples from adults with biopsy‐proven active class III and IV LN from TULIP‐LN (active LN group ...
Hermine I. Brunner +12 more
wiley +1 more source
Twenty-five years of essential medicines
Jonathan D. Quick +3 more
doaj +1 more source

